HEMATOLOGIC AND GENETIC STUDY OF THE TRANSMISSION OF THALASSEMIA
- 1 September 1944
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 74 (3) , 185-196
- https://doi.org/10.1001/archinte.1944.00210210032005
Abstract
Cooley's anemia,1 or thalassemia,2 is a rare but well known disease. This fatal disorder is characterized by a chronic, progressive, hypochromic and microcytic type of anemia, peripheral erythroblastosis, increased number of target and oval red blood cells, decreased fragility of erythrocytes, splenomegaly, deposition of pigment in the viscera and changes in the bones. The condition was early noted to have a familial incidence and to be virtually restricted to the Mediterranean peoples. In 1937, Angelini (quoted from Wintrobe and associates3) observed that in some instances the erythrocytes of apparently healthy parents and of siblings of patients suffering from this anemia showed decreased fragility. Caminopetros4 independently confirmed this observation, finding that 22 of 30 parents tested showed reduced fragility. He also reported slight changes in the bones in some parents. A few years later, Wintrobe, Matthews, Pollack and Dobyns3 described the occurrence in several Italian familiesThis publication has 4 references indexed in Scilit:
- Genetic Control of Biochemical Reactions in NeurosporaProceedings of the National Academy of Sciences, 1941
- ???TARGET CELL??? ANEMIAThe Lancet Healthy Longevity, 1940
- A special form of erythrocyte possessing increased resistance to hypotonic salineThe Journal of Pathology and Bacteriology, 1938
- Mediterranean disease-thalassemia(Erythroblastic anemia of cooley)The Journal of Pediatrics, 1936